Thomas Frisell

35PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersAutoimmunityMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Recommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 17, 2026
Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

|Jun 18, 2026
Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.

|Jun 02, 2026
Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

|Nov 20, 2025
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Simon Englund, Johan Reutfors, Thomas Frisell

|Jul 24, 2025
Completeness and generalizability of the Swedish MS register.

Peter Alping, Thomas Frisell, Anna He

|Jul 10, 2024
Hospital-Treated Infections and Risk of Disability Worsening in Multiple Sclerosis.

Yihan Hu, Thomas Frisell, Peter Alping

Pageof 6

Frequent Collaborators

8 joint publications

Johan Askling

6 joint publications

Hannah Bower

6 joint publications

Peter Alping

5 joint publications

Benedicte Delcoigne